NEO
Ticker
NeoGenomics Inc
Company
Diagnostics
Industry
Healthcare
Sector
Financial Ratio Analysis
+
2009
+
2010
+
2011
+
2012
+
2013
+
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
β€”16.6%26.5%37.7%11.0%31.0%14.6%144.6%-1.6%15.2%47.7%8.7%9.0%5.2%16.1%11.6%β€”10.1%
Revenue Growth QoQ
β€”16.6%26.5%37.7%11.0%31.0%14.6%144.6%-1.6%15.2%47.7%8.7%9.0%5.2%16.1%11.6%β€”β€”
Gross Margin
51.6%45.9%44.7%44.8%47.7%46.8%43.8%45.2%42.4%46.0%48.1%41.8%38.6%36.9%41.3%43.9%β€”43.5%
EBITDA Margin
-1.8%-3.4%3.9%8.4%11.4%9.0%1.5%10.6%10.6%11.5%10.6%4.9%-13.5%-17.3%-5.9%-3.0%β€”-7.2%
Operating Margin
-5.9%-8.6%-0.9%2.0%4.8%2.5%-5.6%1.1%1.2%3.6%3.2%-3.1%-24.5%-30.9%-18.2%-13.9%β€”-17.0%
Profit Margin
-7.6%-9.6%-2.7%0.1%3.1%1.3%-2.5%-2.3%-0.2%1.0%2.0%0.9%-1.7%-28.3%-14.9%-11.9%β€”-16.0%
FCF / EBITDA
452.9%251.1%-49.4%-82.4%2.8%72.3%277.2%54.1%17.1%95.9%7.7%-127.2%138.9%109.9%87.3%174.0%β€”33.3%